Which drug works better for stem cell collection? study compares zarzio and granocyte
NCT ID NCT03367117
First seen Jun 15, 2026 · Last updated Jun 23, 2026 · Updated 1 time
Summary
This completed study looked at 70 patients with myeloma or lymphoma who needed stem cell transplants. Researchers compared two drugs, Zarzio and Granocyte, used to stimulate stem cell production before collection. The goal was to see if one drug led to better stem cell grafts. Since it was a retrospective review, it provides information but cannot prove one drug is better than the other.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGY, GRAFT, MOBILIZATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Study site
Brest, 29200, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Zarzio and Granocyte (both are G-CSF drugs used to stimulate stem cell production)
What this could lead to
If one drug works better, it could help doctors choose the best option for stem cell collection before transplant.
What could go wrong
This is a small, retrospective study (70 patients) that only looks back at past results, so it cannot prove cause and effect. The findings may not apply to all patients.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.